Company: Pacira Pharmaceuticals
Based: San Diego, CA
Investors: Undisclosed Venture Firm, MPM Capital, OrbiMed Advisors, HBM BioVentures, Sanderling Ventures.
Scoop: In November, Pacira Pharmaceuticals extended its Series A round from the original $30 million to $85 million. The company, which is developing several drugs (mostly for pain management), is conducting clinical trials of its experimental treatment Exparel in a number of pain indications. It's also running a Phase III program for DepoBupivacaine for postsurgical pain.